{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T06:49:39Z","timestamp":1773125379267,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.bcp.2006.02.006","type":"journal-article","created":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T13:45:47Z","timestamp":1142343947000},"page":"1435-1448","source":"Crossref","is-referenced-by-count":91,"title":["Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells"],"prefix":"10.1016","volume":"71","author":[{"given":"Michael","family":"H\u00f6pfner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Huether","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas P.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viola","family":"Baradari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Scher\u00fcbl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2006.02.006_bib1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-139-10-200311180-00009","article-title":"The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update","volume":"139","author":"El Serag","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bcp.2006.02.006_bib2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ijc.1456","article-title":"International trends and patterns of primary liver cancer","volume":"94","author":"McGlynn","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2006.02.006_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.gastro.2004.09.018","article-title":"Environmental factors and risk for hepatocellular carcinoma","volume":"127","author":"Yu","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2006.02.006_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.gastro.2004.09.021","article-title":"Obesity and hepatocellular carcinoma","volume":"127","author":"Caldwell","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2006.02.006_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/jhep.2001.21041","article-title":"Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States","volume":"33","author":"El Serag","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2006.02.006_bib6","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0092-8674(94)90023-X","article-title":"Oncogenes and the strategy of growth factors","volume":"79","author":"Baserga","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2006.02.006_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1568009023333863","article-title":"Insulin-like growth factor receptor-1 as an anticancer target: blocking transformation and inducing apoptosis","volume":"2","author":"Wang","year":"2002","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.bcp.2006.02.006_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3748\/wjg.v9.i2.267","article-title":"Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis","volume":"9","author":"Wang","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bcp.2006.02.006_bib9","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/j.1460-2075.1986.tb04528.x","article-title":"Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity","volume":"5","author":"Ulrich","year":"1986","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2006.02.006_bib10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.bjc.6600777","article-title":"Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis","volume":"88","author":"Sedlaczek","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2006.02.006_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1055\/s-2004-814151","article-title":"The role of the IGF axis in hepatocarcinogenesis","volume":"35","author":"Scharf","year":"2003","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.bcp.2006.02.006_bib12","first-page":"2719","article-title":"A novel orthotopic tumor model to study growth factors and oncogenes in hepatocarcinogenesis","volume":"9","author":"Yao","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2006.02.006_bib13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.bcp.2004.05.029","article-title":"An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signaling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis","volume":"68","author":"Alexia","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2006.02.006_bib14","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/jnci\/92.18.1472","article-title":"Role of the insulin-like growth factor family in cancer development and progression","volume":"92","author":"Yu","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bcp.2006.02.006_bib15","first-page":"4127","article-title":"Blockage of insulin-like growth factor I receptor inhibits the growth of Ewing's sarcoma in athymic mice","volume":"58","author":"Scotlandi","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2006.02.006_bib16","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1172\/JCI117441","article-title":"Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma","volume":"94","author":"Shapiro","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2006.02.006_bib17","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1055\/s-2004-814158","article-title":"Development of molecular agents for IGF receptor targeting","volume":"35","author":"Salisbury","year":"2003","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.bcp.2006.02.006_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1535-6108(04)00051-0","article-title":"In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase","volume":"5","author":"Garcia-Echeverria","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2006.02.006_bib19","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1158\/0008-5472.CAN-04-3192","article-title":"Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors","volume":"65","author":"Scotlandi","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2006.02.006_bib20","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2006.02.006_bib21","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1053\/j.gastro.2004.03.077","article-title":"Gastroesophageal reflux among different racial groups in the United States","volume":"126","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2006.02.006_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0006-291X(88)81186-0","article-title":"Evidence of autocrine regulation in human hepatoma cell lines","volume":"153","author":"Tsai","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2006.02.006_bib23","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/carcin\/19.12.2121","article-title":"Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC)","volume":"19","author":"Scharf","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2006.02.006_bib24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0168-8278(98)80263-8","article-title":"Induction of apoptosis in rat hepatocarcinoma cells by expression of IGF-I antisense c-DNA","volume":"29","author":"Ellouk-Achard","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.bcp.2006.02.006_bib25","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1172\/JCI114315","article-title":"Blockade of the type l somatomedin receptor inhibits growth of human breast cancer cells in athymic mice","volume":"84","author":"Arteaga","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2006.02.006_bib26","first-page":"3798","article-title":"In vitro and in vivo profiling of selective and potent IGF-IR kinase inhibitors","volume":"44","author":"Hofmann","year":"2003","journal-title":"Proc AACR"},{"key":"10.1016\/j.bcp.2006.02.006_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/282615a0","article-title":"Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line","volume":"282","author":"Aden","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2006.02.006_bib28","first-page":"3858","article-title":"Growth of human hepatoma cells lines with differentiated functions in chemically defined medium","volume":"42","author":"Nakabayashi","year":"1982","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2006.02.006_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00432-004-0664-6","article-title":"The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells","volume":"131","author":"Ocker","year":"2005","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.bcp.2006.02.006_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0014-4827(02)00011-3","article-title":"Downregulation of p21(waf\/cip-1) mediates apoptosis of human hepatocellular carcinoma cells in response to interferon-gamma","volume":"282","author":"Detjen","year":"2003","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.bcp.2006.02.006_bib31","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/sj.bjc.6601346","article-title":"A novel approach in the treatment of neuroendocrine gastrointestinal tumors: targeting the epidermal growth factor receptor by gefitinib (ZD1839)","volume":"89","author":"H\u00f6pfner","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2006.02.006_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0003-2697(86)90314-3","article-title":"Determination of cell number in monolayer cultures","volume":"159","author":"Gillies","year":"1986","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bcp.2006.02.006_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ijc.10553","article-title":"Meta-iodobenzylguanidine induces growth inhibition and apoptosis of neuroendocrine gastrointestinal tumor cells","volume":"101","author":"H\u00f6pfner","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2006.02.006_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/376037a0","article-title":"Identification and inhibition of the ICE\/CED-3 protease necessary for mammalian apoptosis","volume":"376","author":"Nicholson","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2006.02.006_bib35","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1021\/jm0100537","article-title":"Potent and selective non-peptide inhibitors of caspases-3 and -7","volume":"44","author":"Lee","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2006.02.006_bib36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00384-002-0440-5","article-title":"Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells","volume":"18","author":"H\u00f6pfner","year":"2003","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.bcp.2006.02.006_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-1759(88)90310-9","article-title":"A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity","volume":"115","author":"Decker","year":"1988","journal-title":"J Immunol Meth"},{"key":"10.1016\/j.bcp.2006.02.006_bib38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ijc.10724","article-title":"Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human esophageal cancer cells","volume":"102","author":"Sutter","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2006.02.006_bib39","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1054\/bjoc.2001.2181","article-title":"Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells","volume":"85","author":"Maaser","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2006.02.006_bib40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/sj.bjc.6601125","article-title":"Ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in oesophageal cancer cells: involvement of the p38MAPK signaling pathway","volume":"89","author":"Sutter","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2006.02.006_bib41","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jhep.2004.08.024","article-title":"Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma","volume":"41","author":"H\u00f6pfner","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.bcp.2006.02.006_bib42","doi-asserted-by":"crossref","first-page":"27643","DOI":"10.1074\/jbc.M108863200","article-title":"Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor","volume":"277","author":"Gilmore","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2006.02.006_bib43","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jhep.2005.02.040","article-title":"Erlotinib induces cell cycle arrest and apoptosis in hepatocellular cancer cells and enhances chemosensitivity towards cytostatics","volume":"43","author":"Huether","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.bcp.2006.02.006_bib44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.taap.2003.09.011","article-title":"A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and Bid cleavage","volume":"194","author":"Oh","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bcp.2006.02.006_bib45","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3748\/wjg.v11.i9.1382","article-title":"Antitumor effect of Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with cytotoxic agent on murine hepatocellular carcinoma","volume":"11","author":"Zhu","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bcp.2006.02.006_bib46","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.bcp.2005.09.007","article-title":"EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer","volume":"70","author":"Huether","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2006.02.006_bib47","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1074\/jbc.M306156200","article-title":"The mitogenic action of insulin-like growth factor I in normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase","volume":"279","author":"Ahmad","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2006.02.006_bib48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ijc.11445","article-title":"Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells","volume":"108","author":"Lu","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2006.02.006_bib49","first-page":"19665","article-title":"A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity","volume":"280","author":"Lu","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2006.02.006_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1535-6108(04)00050-9","article-title":"Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors","volume":"5","author":"Mitsiades","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2006.02.006_bib51","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/sj.bjc.6601682","article-title":"Co-targeting IGF-1R and c-kit: synergistic inhibition of proliferation and induction of apoptosis in H 209 small cell lung cancer cells","volume":"90","author":"Camirand","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2006.02.006_bib52","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ijc.11487","article-title":"The IGF-1 receptor in cancer biology","volume":"107","author":"Baserga","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2006.02.006_bib53","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3835(03)00159-9","article-title":"The insulin-like growth factor system and cancer","volume":"195","author":"LeRoith","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2006.02.006_bib54","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jhep.2004.07.015","article-title":"Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1","volume":"41","author":"Sutter","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.bcp.2006.02.006_bib55","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/35004029","article-title":"The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant","volume":"2","author":"Goldstein","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.bcp.2006.02.006_bib56","doi-asserted-by":"crossref","first-page":"19066","DOI":"10.1074\/jbc.M100614200","article-title":"Cytochrome c release occurs via Ca2+-dependent and Ca2+-independent mechanisms that are regulated by Bax","volume":"276","author":"Gogvadze","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2006.02.006_bib57","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1038\/sj.onc.1204490","article-title":"The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway","volume":"20","author":"Liu","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2006.02.006_bib58","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/sj.onc.1202292","article-title":"Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1","volume":"17","author":"Sheikh","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2006.02.006_bib59","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1038\/sj.onc.1202878","article-title":"The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation","volume":"18","author":"Belka","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2006.02.006_bib60","first-page":"2083","article-title":"Mistletoe lectin activates caspase-8\/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis","volume":"59","author":"Bantel","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2006.02.006_bib61","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1074\/jbc.274.12.7987","article-title":"Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs","volume":"274","author":"Micheau","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2006.02.006_bib62","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood.V93.9.3053","article-title":"Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1","volume":"93","author":"Wesselborg","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2006.02.006_bib63","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1038\/sj.onc.1203710","article-title":"The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase-8 in a manner independent of Fas and TNF-alpha receptors","volume":"19","author":"Gil","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2006.02.006_bib64","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1128\/JVI.74.3.1513-1523.2000","article-title":"Alpha\/beta interferons potentiate virus-induced apoptosis through activation of the FADD\/caspase-8 death signaling pathway","volume":"74","author":"Balachandran","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.bcp.2006.02.006_bib65","first-page":"1189","article-title":"Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma","volume":"12","author":"Morinaga","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bcp.2006.02.006_bib66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bjc.6600696","article-title":"Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma","volume":"88","author":"Grabowski","year":"2003","journal-title":"Br J Cancer"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629520600092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629520600092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T04:53:00Z","timestamp":1586753580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629520600092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S000629520600092X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2006.02.006","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}